DIAZYME LABORATORIES INC

Diazyme Laboratories Inc. specializes in biotechnology research and development, focusing on the design, analysis, and optimization of biological systems for public health applications. Their technical expertise includes experimental design, molecular characterization, and translational research methodologies, with a demonstrated capacity to manage complex R&D timelines and adapt key personnel to evolving project requirements. The company’s work centers on advancing non-nanobiotechnology innovations, likely involving protein engineering, assay development, or therapeutic target validation, delivered under strict federal research protocols. Their ability to execute performance extensions and personnel revisions suggests strong project governance and regulatory alignment in federally funded science initiatives. The contractor has delivered services exclusively to the Department of Health and Human Services, indicating a focused relationship centered on advancing biomedical research objectives under HHS oversight. This engagement likely supports initiatives within NIH, CDC, or ASPR, where the need for rigorous, reproducible biotech R&D is critical to public health outcomes. Their contract history reflects a pattern of sustained, mission-aligned collaboration rather than broad agency diversification. Diazyme’s primary industry focus is in NAICS 541714—biotechnology research excluding nanobiotechnology—positioning them as a niche provider of laboratory-based discovery and development services. They operate at the intersection of academic rigor and federal funding priorities, serving the biomedical innovation pipeline with emphasis on preclinical and early-stage research outputs. Their market positioning is that of a specialized R&D contractor, not a product developer or manufacturer. As a small business structured as a 2L entity based in Poway, California, Diazyme Laboratories Inc. operates with a lean, agile framework suited to contract-driven science. While no formal government certifications are listed, their consistent performance under HHS contracts demonstrates compliance with federal research standards and administrative requirements. Their geographic presence in Southern California’s biotech corridor supports access to talent, infrastructure, and collaborative research networks.